6C), compared to MSG group
Chou CW, Wang CC, Wu CP, Lin YJ, Lee YC, Cheng YW, et al
"Making Wegovy available via these telehealth channels, with its clinically-tested weight loss in its premium pen delivery device, is an important step forward in allowing patients to receive care in the way they choose and helping them to achieve their weight loss goals with an authentic, FDA-approved medicine." First approved in 2021, Wegovy is the only FDA-approved semaglutide treatment for weight loss, and the medicine that changed how healthcare professionals (HCPs) treat patients with obesity as the first weekly GLP-1 for chronic weight management
doi: 10.1016/j.jpeds.2016.10.070 20 MastrandreaLDWittenLCarlsson PetriKCHalePMHedmanHKRiesenbergRA
Treatment goals for nausea management are directed to prevent serious complications of persistent vomiting that could lead to hypovolemia and vitamin deficiencies that could lead to more serious conditions including but not limited to renal failure, cardiac abnormalities and electrolyte imbalances that could be fatal
You start with daily shots for a week